Additionally, no alterations in plasma IFN-γ, TNF-α, or IL-6 concentrations were attributed to SNS-101 at any time point or dose level, substantiating previous in vitro, ex vivo and in vivo CRS model data (Supplementary Data File 1). Here, IL6 is linked to congenital rubella syndrome.